Stock Events

Stock Events

Biomerieux 

$8.70
124
-$0.27-2.98% Friday 19:46

Statistics

Day High
8.75
Day Low
8.7
52W High
14.62
52W Low
7.12
Volume
1,540
Avg. Volume
1,435
Mkt Cap
1.03B
P/E Ratio
21.14
Dividend Yield
1.3%
Dividend
0.11

Upcoming

Dividends

1.3%Dividend Yield
Jun 26
$0.11
Jun 25
$0.10
Jun 24
$0.09
Jun 23
$0.09
Jun 17
$0.04
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
7.32%
1Y Growth
9.26%

Earnings

28JulExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0
0.73
1.46
2.19
Expected EPS
2.03600289676
Actual EPS
1.99588461308

Financials

9.95%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
4.69BRevenue
467.26MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BMXXY. It's not an investment recommendation.
Air Liquide
27
AI.PA
Sanofi
25
SAN.PA
TotalEnergies
23
TTE.PA
Lvmh Moet Hennessy Louis Vuitton
18
MC.PA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a broad range of analytical instruments and reagents, directly competing in the diagnostics and research sectors similar to Biomerieux.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation, through its subsidiaries like Cepheid, competes in the life sciences and diagnostics market, offering products that overlap with Biomerieux's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories provides a variety of products for the life science research and clinical diagnostics markets, making it a direct competitor in several areas of Biomerieux's business.
Resmed
RMD
Mkt Cap34.67B
ResMed Inc. is known for its products in the health sector, including diagnostics, where it competes with Biomerieux in certain niches.
Becton Dickinson
BDX
Mkt Cap51.62B
Becton, Dickinson and Company operates in the healthcare and diagnostics industries, offering products and services that compete with Biomerieux's diagnostics solutions.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen N.V. offers technologies and products for preanalytical sample preparation and diagnostics, competing in the molecular diagnostics market alongside Biomerieux.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories has a broad range of healthcare products including diagnostics, competing with Biomerieux especially in the areas of infectious disease testing.
Agilent Technologies
A
Mkt Cap43.38B
Agilent Technologies provides analytical instruments, services, and consumables in the life sciences, diagnostics, and applied chemical markets, competing with Biomerieux in laboratory diagnostics.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health operates in the precision oncology field, offering liquid biopsy tests that compete with Biomerieux's molecular diagnostics solutions in the oncology segment.

About

bioMérieux S.A. is a global leader in the development and production of in vitro diagnostic solutions, primarily aimed at detecting infectious diseases. Its operations span the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. The company provides sophisticated diagnostic platforms that analyze biological specimens to pinpoint infectious diseases, cardiovascular conditions, and various cancers. Additionally, it offers microbiological testing for quality control in manufacturing, serving the food, pharmaceutical, cosmetics, and veterinary industries. Its diverse clientele encompasses clinical and hospital laboratories, medical practitioners, blood banks, and industrial control facilities. Founded in 1963, the company, previously known as B-D Mérieux, maintains its headquarters in Marcy l'Etoile, France. bioMérieux S.A. operates as a subsidiary of Institut Mérieux SA.
Show more...
CEO
Pierre Boulud
Employees
15078
Country
France
ISIN
US09074E1010

Listings

OTC Link
US
BMXXY
STU
DE
EYWN.STU
MU
DE
EYWN.MU
PA
FR
BIM.PA

0 Comments

Share your thoughts

FAQ

What is Biomerieux stock price today?▼
The current price of BMXXY is $8.70 USD — it has decreased by -2.98% in the past 24 hours. Watch Biomerieux stock price performance more closely on the chart.
What is Biomerieux stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Biomerieux stocks are traded under the ticker BMXXY.
Is Biomerieux stock price growing?▼
BMXXY stock has risen by +2.53% compared to the previous week, the month change is a +4.95% rise, over the last year Biomerieux has showed a -40.49% decrease.
What is Biomerieux market cap?▼
Today Biomerieux has the market capitalization of 1.03B
When is the next Biomerieux earnings date?▼
Biomerieux is going to release the next earnings report on March 04, 2027.
What were Biomerieux earnings last quarter?▼
BMXXY earnings for the last quarter are 2.27 USD per share, whereas the estimation was 2.32 USD resulting in a -1.97% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Biomerieux revenue for the last year?▼
Biomerieux revenue for the last year amounts to 4.69B USD.
What is Biomerieux net income for the last year?▼
BMXXY net income for the last year is 467.26M USD.
Does Biomerieux pay dividends?▼
Yes, BMXXY dividends are paid annual. The last dividend per share was 0.11 USD. As of today, Dividend Yield (FWD)% is 1.3%.
How many employees does Biomerieux have?▼
As of September 05, 2026, the company has 15,078 employees.
In which sector is Biomerieux located?▼
Biomerieux operates in the Health & Wellness sector.
When did Biomerieux complete a stock split?▼
The last stock split for Biomerieux was on September 21, 2017 with a ratio of 3:1.
Where is Biomerieux headquartered?▼
Biomerieux is headquartered in Marcy l'Étoile, France.